NextCell Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022
Cash & Equivalents	32.33	26.03	38.72	46.79	50.03	97.12
Cash & Short-Term Investments	32.33	26.03	38.72	46.79	50.03	97.12
Cash Growth	-5.25%	-32.77%	-17.24%	-6.47%	-48.49%	-30.22%
Accounts Receivable	3.7	3.06	3	1.67	2.35	1.78
Other Receivables	11.25	2.4	1.98	1.45	1.24	0.93
Receivables	14.95	5.47	4.98	3.12	3.58	2.71
Inventory	0.33	0.33	0.55	0.55	0.79	0.77
Prepaid Expenses	-	9.57	10.15	10.17	12.87	6.16
Other Current Assets	-	-	-	0.05	0	-
Total Current Assets	47.61	41.4	54.4	60.67	67.27	106.75
Property, Plant & Equipment	13.96	14.27	14.33	12.66	13.55	9.9
Long-Term Investments	8.25	7.2	6.87	6.92	6.87	6.87
Other Long-Term Assets	-	1.05	1.14	1.03	1.13	1.13
Total Assets	69.82	63.92	76.73	81.29	88.83	124.66
Accounts Payable	5.01	3.34	2.69	6.16	0.89	1.92
Accrued Expenses	-	3.38	2.25	2.49	7.65	4.16
Current Unearned Revenue	-	-	-	0.25	0.2	-
Other Current Liabilities	4.71	1.31	0.49	0.98	1.35	0.85
Total Current Liabilities	9.72	8.03	5.43	9.87	10.08	6.93
Long-Term Unearned Revenue	-	5.29	4.92	3.82	3.02	2.18
Other Long-Term Liabilities	5.11	0	-0	-0	-0	-
Total Liabilities	14.83	13.32	10.34	13.69	13.1	9.12
Common Stock	25.91	22.84	22.84	14.98	7.05	7.05
Additional Paid-In Capital	260.11	248.41	248.41	222.33	196.43	196.43
Retained Earnings	-231.03	-220.64	-204.85	-169.71	-127.75	-87.94
Comprehensive Income & Other	0	-	-	-	-	-
Shareholders' Equity	54.99	50.6	66.39	67.6	75.73	115.54
Total Liabilities & Equity	69.82	63.92	76.73	81.29	88.83	124.66
Net Cash (Debt)	32.33	26.03	38.72	46.79	50.03	97.12
Net Cash Growth	-5.25%	-32.77%	-17.24%	-6.47%	-48.49%	-30.22%
Net Cash Per Share	-	-	0.51	1.15	1.46	2.82
Filing Date Shares Outstanding	-	111.39	111.39	73.09	34.38	34.38
Total Common Shares Outstanding	-	111.39	111.39	73.09	34.38	34.38
Working Capital	37.89	33.37	48.97	50.8	57.19	99.82
Book Value Per Share	-	0.45	0.60	0.92	2.20	3.36
Tangible Book Value	54.99	50.6	66.39	67.6	75.73	115.54
Tangible Book Value Per Share	-	0.45	0.60	0.92	2.20	3.36
Machinery	-	-	-	16.04	5.22	5.15
Construction In Progress	-	-	-	-	11.59	7.56